✦ LIBER ✦

A 2-week multiple ascending dose, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of oral AEB071, a protein kinase C inhibitor, in moderate to severe psoriasis patients

Book ID: 116583931
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 49 KB
Volume: 58
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2007.10.531

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

162 A RANDOMIZED DOUBLE-BLIND, PLACEBO-C

162 A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF OCR-002 IN HEALTHY VOLUNTEERS

✍ P. Jochelson; J.L. van de Wetering; J. Bornstein; M. Resler; K. Anderson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A phase IV randomized, double-blind, pla

A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efalizumab in patients with moderate to severe plaque psoriasis involving the scalp

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study using the standardized Psoriasis Area and Severity Index (PASI) to evaluate the efficacy and safety of oral-PUVA in patients with chronic plaque psoriasis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A placebo-controlled, double-blind, dose

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

✍ Peter E Morris; Brian Zeno; Andrew C Bernard; Xiangning Huang; Shampa Das; Timi 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 300 KB

Preliminary assessment of the safety and

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study

✍ H. Nagashima; M. Suzuki; S. Araki; T. Yamabe; C. Muto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 692 KB